Secukinumab in the treatment of psoriasis: patient selection and perspectives

Eric J Yang,1,2 Kristen M Beck,1 Wilson Liao1 1Department of Dermatology, University of California San Francisco, San Francisco, CA, USA; 2Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA Abstract: Secukinumab is a human monoclonal antibody targeti...

Full description

Bibliographic Details
Main Authors: Yang EJ, Beck KM, Liao W
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Psoriasis : Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/secukinumab-in-the-treatment-of-psoriasis-patient-selection-and-perspe-peer-reviewed-article-PTT